What is Hyperfine?
Hyperfine is revolutionizing medical imaging by developing accessible and affordable magnetic resonance imaging (MRI) solutions. Based in Guilford, Connecticut, the company's technology aims to democratize advanced diagnostic capabilities, enabling wider adoption in various clinical settings. Their focus on affordability and accessibility positions them as a key player in the medtech industry, addressing critical gaps in current healthcare infrastructure.
How much funding has Hyperfine raised?
Hyperfine has raised a total of $5.3M across 2 funding rounds:
Debt
$350K
Series D
$5M
Debt (2020): $350K with participation from PPP
Series D (2021): $5M led by Huami, Axiom Associates, Huami Corporation, GV, LSS, Colle Capital, Nextrans, and Altium Capital
Key Investors in Hyperfine
Huami
Huami, a biometric and activity-data-driven company, manufactures smart wearable technology and offers mobile apps for data analysis. They are also a sole partner of Xiaomi for designing and manufacturing Xiaomi-branded smart devices.
GV
GV is a venture capital firm that invests across multiple stages and sectors, focusing on enterprise solutions, life sciences, consumer products, and frontier technology innovations globally.
Colle Capital
Colle Capital Partners is a global early-stage technology venture fund that invests in innovative entrepreneurs, emphasizing data for investment management and agility.
What's next for Hyperfine?
With its recent major strategic investment, Hyperfine is poised for significant expansion and further technological development. The substantial capital infusion, part of its enterprise-level funding, will likely be directed towards scaling manufacturing operations, enhancing its product portfolio, and broadening its market reach. This strategic backing suggests a trajectory towards wider commercialization and adoption of its groundbreaking MRI technology, potentially transforming patient care and diagnostic accessibility globally.
See full Hyperfine company page
